| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2008 | CN101152152A Lgecycline composition for injection and processes for producing same |
| 04/02/2008 | CN101152150A Preparation of paclitaxel carried medicine sustained-release microsphere by supercritical fluid technique |
| 04/02/2008 | CN101152149A Trigone-leaf dioscorea opposita saponin liposome, method for preparing the same and use of the same |
| 04/02/2008 | CN101152148A Kusnezoff monkshood root esculin microemulsion and its preparation |
| 04/02/2008 | CN101152147A Ligustrazine compound emulsion and method for preparing the same |
| 04/02/2008 | CN101152146A Hydrochloric acid olprinone injection and method for preparing the same |
| 04/02/2008 | CN101152144A Buccal preparation containing levorotation ofloxacin and method for preparing the same |
| 04/02/2008 | CN101152143A Solid pharmaceutical composition containing agomelatine |
| 04/02/2008 | CN101152142A Solid pharmaceutical composition containing 2-(3-cyano-4- isobutoxy phenyl)-4-methyl-5-thiazole methanoic acid |
| 04/02/2008 | CN101152129A Collagen produced accelerant, dressing material, and method for producing collagen |
| 04/02/2008 | CN100378140C Block copolymer reduced in impurity content, polymeric carrier, pharmaceutical preparations in polymeric form and process for preparation of the same |
| 04/02/2008 | CN100378119C Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 04/02/2008 | CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one |
| 04/02/2008 | CN100378112C Novel carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 04/02/2008 | CN100378109C Tetracyclic 3-substituted indoles having serotonin receptor affinity |
| 04/02/2008 | CN100378108C Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 04/02/2008 | CN100378107C Oxazolo-and-furopyrimidines and their use as medicaments against tumors |
| 04/02/2008 | CN100378104C 1H-pyranyl[3,4d][1,2,3] tri-azonyl-4-ketonic compound, synthetic method and use |
| 04/02/2008 | CN100378101C 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378097C Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists |
| 04/02/2008 | CN100378096C Diazepanes derivatives useful as LFA inhibitors |
| 04/02/2008 | CN100378095C Substituted indoles as alpha-1 agonists |
| 04/02/2008 | CN100378094C Novel 2-pyridinecarboxamide derivatives |
| 04/02/2008 | CN100378093C Method for preparing optical purity or optically concentrated sulfoxide compounds comprising amorphous esomeprazole and its salts |
| 04/02/2008 | CN100378092C Biphenyl derivatives |
| 04/02/2008 | CN100378090C Substituted dioxopentacyclic derivative and its use in preparing neuro regulator |
| 04/02/2008 | CN100378087C Novel ascorbic acid compounds, methods of synthesis and application use thereof |
| 04/02/2008 | CN100378086C Novel piperazine derivatives and their use as synthesis intermediates |
| 04/02/2008 | CN100378083C Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 04/02/2008 | CN100378079C Process for preparing 17-allyl amino geldanamycin (17-AAG) and other ansamycins |
| 04/02/2008 | CN100378076C Pyridine carboxamide derivatives and their use as pesticides |
| 04/02/2008 | CN100378075C Aniline derivative using as phosphodiesterase 4 inhibitor |
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/02/2008 | CN100378073C Dindoly methylane and preparation process thereof |
| 04/02/2008 | CN100378064C Active metabolic product of phencynonate and its medicinal use |
| 04/02/2008 | CN100378063C Novel compounds and medicinal use thereof |
| 04/02/2008 | CN100378047C Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 04/02/2008 | CN100377745C Stabilized medicine preparation form with by porous kietyoite covering flavour |
| 04/02/2008 | CN100377743C Process for the preparation of a nutrient formulation |
| 04/02/2008 | CN100377735C Ganoderma lucidum buccal tablet |
| 04/02/2008 | CN100377732C Chinese-medicinal preparation for treating wet beriberi |
| 04/02/2008 | CN100377729C Bag with Chinese medicinal powder for treating asthma and cough |
| 04/02/2008 | CN100377727C Wind-expelling pain-relieving liquid and method for preparing same |
| 04/02/2008 | CN100377722C Liquid-state preparation of Chinese medicine |
| 04/02/2008 | CN100377719C Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia |
| 04/02/2008 | CN100377718C Alcohol-neutralizing agent composition containing hyaluronic acid |
| 04/02/2008 | CN100377717C Glycosaminoglycans for treating emotional dysfunctions |
| 04/02/2008 | CN100377716C Preparation method of clindamycin phosphate solution formulation and its applying sheet |
| 04/02/2008 | CN100377715C Medicinal composition for curing cerebrovascular disease |
| 04/02/2008 | CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation |
| 04/02/2008 | CN100377713C Composition for contraception |
| 04/02/2008 | CN100377712C Cucurbitacin lipsome preparation method and formulation |
| 04/02/2008 | CN100377711C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol |
| 04/02/2008 | CN100377710C Aromatase inhibition to enhance assisted reproduction |
| 04/02/2008 | CN100377709C Use of acceptor tyrosine kinases inhibitor and related detecting method |
| 04/02/2008 | CN100377708C Method for preparing tablet of hydroxy camptothecin and application of oral application |
| 04/02/2008 | CN100377707C Application of cucoline in preparation of medicine for treating macular degeneration, pigmentary degeneration of retina and diabetes retinosis |
| 04/02/2008 | CN100377706C A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 04/02/2008 | CN100377705C Calcium hydrophenyl sulfonate capsule and its preparation process |
| 04/02/2008 | CN100377704C Liposomal formulations |
| 04/02/2008 | CN100377656C Method for preparing soymilk contg. micron ginseng, antler. pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 04/02/2008 | CN100377654C Method for preparing sour soymilk containing micron ginseng, antler pearl and pollen pini for tonifying-Yang, dispelling-fatigue and enriching-calcium |
| 04/02/2008 | CN100377645C Substituted arylpyrazoles as parasiticidal agents |
| 04/01/2008 | US7351861 Halo-substituted N-arylanilides with one or more hydroxy groups that may be esterified; N-benzilideneiminoarylamides; antibacterial agents |
| 04/01/2008 | US7351860 Method and device for producing formic acid formates and use of said formates |
| 04/01/2008 | US7351859 Heat activated tertiary amine urethane catalysts |
| 04/01/2008 | US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/01/2008 | US7351857 2-{6-[1-Ethyl-3-(4-trifluoromethoxyphenyl)ureido]-5,6,7,8-tetrahydronaphthalen-2-ylsulfanyl}-2-methylpropionic acid; peroxisome proliferator activated receptors agonist; antidiabetic, dietetics, hypotensive and hypoglycemic agent; dyslipidemia |
| 04/01/2008 | US7351855 Chemically defined non-polymeric valency platform molecules and conjugates thereof |
| 04/01/2008 | US7351846 Oxaliplatin with a low content of accompanying impurities and a method for preparation thereof |
| 04/01/2008 | US7351844 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |
| 04/01/2008 | US7351843 [5-(2-fluorophenyl)furan-2-ylcarbonyl]guanidine; (sodium-hydrogen exchanger isoform 1 (NHE-1) inhibitor; ischemia/reperfusion, myocardial infarction, arrhythmia, angina pectoris |
| 04/01/2008 | US7351842 Compounds for treatment of cardiac arrhythmia and methods of use |
| 04/01/2008 | US7351841 Heterocyclic compounds and thrombopoietin receptor activators |
| 04/01/2008 | US7351840 Perindopril |
| 04/01/2008 | US7351839 Process for the preparation of 1,2,3,4,8,9,10, 10a-octahydro-7bH-cyclopenta[b][1,4]diazepino-[6,7,1-hi]indole derivatives |
| 04/01/2008 | US7351836 Antiinflammatory agents |
| 04/01/2008 | US7351834 Sorafenib and salts such as tosylate (N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea); serine-threonine kinase inhibitor; antitumor and anticarcinogenic agent |
| 04/01/2008 | US7351830 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors |
| 04/01/2008 | US7351828 Benzimidazoles that are useful in treating sexual dysfunction |
| 04/01/2008 | US7351827 Substituted oxetanes, method of making, and method of use thereof |
| 04/01/2008 | US7351826 Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/01/2008 | US7351813 Expression vector coding heterologous protein for use in human therapeutics; for treatment of blood nd liver disorders |
| 04/01/2008 | US7351809 Glycerol carbonate glycoside |
| 04/01/2008 | US7351746 Anti-atherosclerosis composition containing carotenoids and method for inhibiting LDL oxidation |
| 04/01/2008 | US7351745 Reducing fine lines and/or wrinkles in skin by applying S-Methyl-L-Cysteine or S-Phenyl-L-Cysteine to increase gene expression levels of: Beta-catenin, Collagen 4, Collagen 7, Frizzled 10, Estrogen Receptor alpha, and/or Hyaluronic acid synthase |
| 04/01/2008 | US7351743 Therapeutic guanidines |
| 04/01/2008 | US7351742 Sulfonamide derivatives for the treatment of diseases |
| 04/01/2008 | US7351741 4-(4-chloro2-hydroxybenzoylamino)butyric acid or salts for delivering an agent that would otherwise be destroyed or rendered less effective by conditions encountered before the agent reaches its target zone |
| 04/01/2008 | US7351740 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 04/01/2008 | US7351739 Bioactive compounds and methods of uses thereof |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | US7351737 4-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activity |
| 04/01/2008 | US7351736 Therapeutic compositions (II) |
| 04/01/2008 | US7351735 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |